• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Phathom













































$PHAT is on the radar of retail investors, lots of memes so nice rally. It is the perfect acquistion target so perosnally also expect an imminent buyout. 30-50% acquistion premium so 22-24 feasible. Pretty safe bet give all the history now on vonoprazan.
 




















Word is the deal will be announced after the close of business this Friday. Hearing price in the $25 range.
Dumbest post yet!! You obviously haven’t been in pharma long. Never happens on a Friday. Announcements are made on Monday or Tuesday at the latest so it allows investors to jump on. Especially not on a holiday weekend. This is a rep that probably got fired for low numbers and wants to make the rest of us worry for no reason. Now I am not saying it won’t happen but it won’t be for a good 6 months or year.
 




Interesting thread. I believe there is some truth to what has been posted. My experience is that deals are best announced at the beginning of the week and I have been in two acquisitions, both announced Monday and NO ONE at my salary level had any clue (I made a killing on one deal, the other nada). Not happening this weekend for sure...but I am 100% sure a deal will get done before Q3 are released....
 




Interesting thread. I believe there is some truth to what has been posted. My experience is that deals are best announced at the beginning of the week and I have been in two acquisitions, both announced Monday and NO ONE at my salary level had any clue (I made a killing on one deal, the other nada). Not happening this weekend for sure...but I am 100% sure a deal will get done before Q3 are released....
Crazy how you’re 100% sure when you just stayed people at your level have no clue.